USD 45.7
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | 341.29 Million | -73.45 Million |
Net Income | 253.08 Million | -292.2 Million | 435.7 Million | 197.96 Million | 341.29 Million | -73.45 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 55.25 Million | 42.97 Million |
Other non-cash items | -253.08 Million | 292.2 Million | -435.7 Million | -197.96 Million | -341.29 Million | 73.45 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | -108.1 Million | -132.89 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -4.09 Million | -28.96 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | 1.84 Million | -3.07 Million |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 53.41 Million | 46.05 Million |
Cash at beginning of period | - | - | 123.9 Thousand | - | -10.00 | 206.67 Thousand |
Cash at end of period | - | - | 123.9 Thousand | - | 233.18 Million | -206.34 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 233.18 Million | -206.54 Million |
Free Cash Flow | - | - | - | - | 341.29 Million | -73.45 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 253.08 Million | 110.89 Million | 142.18 Million | -292.2 Million | 24.65 Million | -316.86 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -253.08 Million | -110.89 Million | -142.18 Million | 292.2 Million | -24.65 Million | 316.86 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
5287
8933
AIBG
CHGCY
EWC
SYR